← 產業報告目錄

Biobanking Market by Product (Equipment, Consumables, Software), Services (Virtual), Operation (Automated), Workflow (Storage, Collection, Transport), Sample (Blood, Cell Lines, Nucleic Acids), Application, Ownership, End User - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-08-23頁數 492報告編號 BT1224

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The biobanking market is projected to reach USD 11.82 billion by 2030 from USD 7.65 billion in 2025, at a CAGR of 9.1% during the forecast period. The growing focus on precision medicine and the expanding pipeline for cell and gene therapies are set to significantly fuel the growth of the biobanking market. Precision medicine, which tailors treatments to individual genetic profiles, is increasingly driving the need for high-quality, well-preserved biological samples, as these form the foundation for personalized therapies. Additionally, the growing pipeline for cell and gene therapies is expected to be a major driver for the biobanking market in the coming years. The development of new cell and gene therapies, which often rely on stem cells, gene editing, and other advanced biotechnologies, necessitates storing and managing vast amounts of biological material. Biobanks are essential in supporting these therapies by providing a reliable and standardized platform for sample storage, processing, and distribution. The physical biobanking segment accounted for the largest share of the biobanking services market in 2024. Based on services, the biobanking market is segmented into physical biobanking, virtual biobanking, and other services. In 2024, the large share of physical biobanking services in the market can be attributed to the essential role they play in sample collection, storage, and preservation under controlled conditions. Physical biobanks offer the infrastructure necessary to store a wide range of biological samples, including blood, tissues, and DNA, in environments such as freezers, cryogenic tanks, and refrigerators, ensuring sample integrity for long-term use. As the demand for high-quality biological specimens grows, driven by advancements in precision medicine and genomics, physical biobanks are crucial for maintaining the stability and accessibility of these samples. Additionally, the ability to provide reliable, on-site sample management and real-time monitoring systems has further cemented the importance of physical biobanks in supporting pharmaceutical, biotechnology, and research sectors. By ownership, the private/commercial providers segment accounted for the largest share of the market in 2024. Based on the ownership model, the biobanking services market is segmented into private/commercial providers, academic & research institutional biobanks, national/regional agencies, hybrid/PPP (public-private-partnership) models, and other ownership models. In 2024, the private/commercial providers segment accounted for the largest share of the global biobanking market. The large share of the private/commercial providers model in the biobanking market is primarily driven by the growing demand for high-quality, scalable, and commercially viable biobanking solutions. These providers can offer advanced, state-of-the-art infrastructure and technology for sample storage, processing, and distribution, often tailored to meet the specific needs of pharmaceutical, biotechnology, and clinical research sectors. Commercial providers are also more agile in adopting innovations and expanding their services to meet the evolving demands of precision medicine, genomic research, and clinical trials. Their ability to provide comprehensive, end-to-end biobanking services and focus on efficiency and regulatory compliance has made them essential partners for organizations seeking reliable and standardized biological sample management. As a result, the private/commercial ownership model continues to dominate the market, with private players capturing a significant share. The US dominated the biobanking market in 2024. In 2024, the US held a significant share of the North American biobanking market, driven by its advanced healthcare infrastructure, substantial investment in research and development, and leading role in precision medicine. With numerous world-renowned academic institutions, pharmaceutical companies, and research organizations, the US is at the forefront of generating and utilizing biological samples for a wide range of scientific advancements. The growing emphasis on personalized medicine, genomics, and clinical trials has increased the demand for high-quality biobanks in the region. Additionally, favorable regulatory frameworks and substantial public and private funding continue to support the expansion of biobanking services, solidifying the dominant position of the US in the market. The primary interviews conducted for this report can be categorized as follows: • By Respondent: Supply-side- 70% and Demand-side 30% • By Designation: Managers - 45%, CXOs & Directors - 30%, and Executives - 25% • By Region: North America - 40%, Europe -25%, Asia Pacific -25%, Latin America -5% and the Middle East & Africa- 5% List of Companies Profiled in the Report: • Thermo Fisher Scientific Inc. (US) • Merck KGaA (Germany) • PHC Holdings Corporation (Japan) • Becton, Dickinson and Company (BD) (US) • Qiagen (Germany) • Merck KGaA (Germany) • Labcorp (US) • Eurofins Scientific (Luxembourg) • Cryoport (US) • ICON Plc (Ireland) • Tecan Trading AG (Switzerland) • Azenta US Inc. (US) • Avantor, Inc. (US) • Greiner AG (Austria) • Amsbio (UK) • Labcorp (US) • Eurofins Scientific (Luxembourg) • Hamilton Company (US) • BioIVT LLC (US) • BioKryo (Germany) • ASKION GmbH (Germany) • Sopachem (Belgium) • Froilabo (UK) • Cureline (US) • SPT Labtech Ltd (UK) Research Coverage This research report categorizes the biobanking market by offerings [products (equipment, consumables), services (physical biobanking, virtual biobanking, other services), software]; workflow (sample collection & storage, sample processing, sample analysis, transport & logistics), operation type (manual, automated), sample type (blood products, solid tissues & organs, stem cell & cell lines, nucleic acids, biological fluids, human waste products), end user- product (biobanks, CROs), end -user services (pharma, biotech & CROs, academic & research institutes), and region (North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa). The report's scope covers detailed information regarding the leading factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the biobanking market. A thorough analysis of the key industry players has provided insights into their business overview, services, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations, and acquisitions are the recent developments associated with the biobanking market. Key Benefits of Buying the Report The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the overall biobanking market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges. The report provides insights on the following pointers: • Analysis of key drivers (growing focus on precision medicine & population-genomics programmes, cell- & gene-therapy pipeline expansion, adoption of energy-efficient Ultra Low Temperature(ULT) freezers, end-to-end automation & robotics for physical sample handling and storage), restraints (high upfront capital expenditure, sample quality variability), opportunities ( outsourcing of cryogenic storage to third-party specialists, growing focus on sustainability and green-lab solutions), and challenges (long-term funding stability for public biobanks) influencing the growth of the market. • Product/Service Development/Innovation: Detailed insights on newly launched products, services of the biobanking market • Market Development: Comprehensive information about lucrative markets - the report analyzes the market across varied regions. • Market Diversification: Exhaustive information about new products, services, untapped geographies, recent developments, and investments in the biobanking market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product & service offerings of key players including Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), PHC Holdings Corporation (Japan), Becton, Dickinson and Company (BD) (US), Qiagen (Germany), Labcorp (US), Eurofins Scientific (Luxembourg), Cryoport (US). A detailed analysis of the key industry players has been conducted to provide insights into their key strategies, product launches, acquisitions, partnerships, agreements, collaborations, expansions, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the biobanking product and service market.
目錄 Table of Contents
1 INTRODUCTION 46 1.1 STUDY OBJECTIVES 46 1.2 MARKET DEFINITION 46 1.3 STUDY SCOPE 46 1.3.1 BIOBANKING MARKET SEGMENTATION & REGIONAL SCOPE 47 1.3.2 INCLUSIONS & EXCLUSIONS 48 1.3.3 YEARS CONSIDERED 49 1.3.4 CURRENCY CONSIDERED 50 1.4 STAKEHOLDERS 50 1.5 SUMMARY OF CHANGES 50 2 RESEARCH METHODOLOGY 52 2.1 RESEARCH DATA 52 2.1.1 SECONDARY DATA 53 2.1.1.1 Key sources of secondary data 53 2.1.1.2 Key objectives of secondary research 53 2.1.2 PRIMARY DATA 54 2.1.2.1 Breakdown of primaries 54 2.1.2.2 Key objectives of primary research 55 2.2 MARKET ESTIMATION METHODOLOGY 55 2.2.1 GLOBAL MARKET SIZE ESTIMATION, 2024 55 2.2.1.1 Company revenue analysis (bottom-up approach) 55 2.2.1.2 MnM repository analysis 57 2.2.1.3 Primary interviews 58 2.2.1.4 Insights from primary sources 58 2.2.2 SEGMENTAL MARKET ASSESSMENT (TOP-DOWN APPROACH) 58 2.3 MARKET GROWTH RATE FORECAST 60 2.3.1 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS 61 2.3.2 BIOBANKING MARKET: GROWTH ANALYSIS OF MARKET DYNAMICS 62 2.4 DATA TRIANGULATION 62 2.5 STUDY ASSUMPTIONS 63 2.6 RESEARCH LIMITATIONS 64 2.7 RISK ANALYSIS 65 3 EXECUTIVE SUMMARY 66 3.1 KEY INSIGHTS & MARKET HIGHLIGHTS 66 3.2 STRATEGIC IMPERATIVES FOR STAKEHOLDERS 70 3.2.1 BIOBANKING EQUIPMENT MANUFACTURERS 70 3.2.2 BIOBANKING CONSUMABLE MANUFACTURERS 70 3.2.3 BIOBANKING SERVICE PROVIDERS 71 4 PREMIUM INSIGHTS 72 4.1 BIOBANKING MARKET OVERVIEW 72 4.2 NORTH AMERICA: BIOBANKING MARKET, BY OFFERING AND COUNTRY, 2024 73 4.3 BIOBANKING PRODUCTS MARKET SHARE, BY END USER, 2024 73 4.4 BIOBANKING SERVICES MARKET SHARE, BY END USER, 2024 74 4.5 BIOBANKING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 74 5 MARKET OVERVIEW 75 5.1 INTRODUCTION 75 5.2 MARKET DYNAMICS 75 5.2.1 DRIVERS 76 5.2.1.1 Growing focus on precision medicine & population genomics programs 76 5.2.1.2 Expansion of cell & gene therapy pipeline 77 5.2.1.3 Adoption of energy-efficient ULT freezers 77 5.2.1.4 Integration of end-to-end automation & robotics for sample handling & storage 78 5.2.2 RESTRAINTS 78 5.2.2.1 High capital expenditure 78 5.2.2.2 Variability associated with sample quality 79 5.2.3 OPPORTUNITIES 79 5.2.3.1 Outsourcing of activities by SME biopharma companies to third-party specialists 79 5.2.3.2 Increasing focus on sustainability & green-lab solutions 80 5.2.4 CHALLENGES 80 5.2.4.1 Challenges associated with long-term funding stability for public biobanks 80 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81 5.3.1 STRATEGIC ANALYSIS OF GROWTH OPPORTUNITIES 81 5.4 PRICING ANALYSIS 82 5.4.1 AVERAGE SELLING PRICE OF BIOBANKING PRODUCTS, BY KEY PLAYER, 2024 82 5.4.2 INDICATIVE PRICING OF BIOBANKING SERVICES, BY SERVICE TYPE, 2024 83 5.4.3 INDICATIVE PRICING TREND FOR BIOBANKING MARKET, BY REGION, 2022−2024 83 5.5 VALUE CHAIN ANALYSIS 84 5.6 ECOSYSTEM ANALYSIS 85 5.6.1 ROLE IN ECOSYSTEM 86 5.6.2 EMERGING BUSINESS MODELS & ECOSYSTEM SHIFT IN BIOBANKING MARKET 88 5.7 PATENT ANALYSIS 88 5.8 LIST OF KEY PATENTS 90 5.9 TECHNOLOGY ANALYSIS 91 5.9.1 KEY TECHNOLOGIES 91 5.9.1.1 Automated sample collection and processing technologies 91 5.9.1.2 Sample analysis technologies 91 5.9.2 COMPLEMENTARY TECHNOLOGIES 92 5.9.2.1 Data management & informatics 92 5.9.2.2 AI & ML in biobanking 92 5.10 KEY CONFERENCES & EVENTS, 2025−2026 93 5.11 REGULATORY ANALYSIS 93 5.11.1 REGULATORY FRAMEWORK 94 5.11.1.1 North America 94 5.11.1.2 Europe 94 5.11.1.3 Asia Pacific 94 5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95 5.12 TRADE ANALYSIS 96 5.12.1 IMPORT DATA FOR HS CODE 8418, 2020–2024 96 5.12.2 EXPORT DATA FOR HS CODE 8418, 2020–2024 97 5.13 PORTER’S FIVE FORCES ANALYSIS 97 5.13.1 THREAT OF NEW ENTRANTS 98 5.13.2 THREAT OF SUBSTITUTES 99 5.13.3 BARGAINING POWER OF BUYERS 99 5.13.4 BARGAINING POWER OF SUPPLIERS 99 5.13.5 INTENSITY OF COMPETITIVE RIVALRY 99 5.14 KEY STAKEHOLDERS & BUYING CRITERIA 100 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 100 5.14.2 KEY BUYING CRITERIA FOR BIOBANKING PRODUCTS, BY END USER 101 5.14.3 KEY BUYING CRITERIA FOR BIOBANKING SERVICES, BY END USER 102 5.14.4 UNMET NEEDS & WHITE SPACES 103 5.15 INVESTMENT & FUNDING SCENARIO 104 5.15.1 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE, 2024 105 5.16 IMPACT OF AI/GEN AI ON BIOBANKING MARKET 105 5.16.1 INTRODUCTION 105 5.16.2 USE CASES 105 5.16.3 FUTURE OF AI IN BIOBANKING MARKET ECOSYSTEM 106 5.17 IMPACT OF 2025 US TARIFF ON BIOBANKING MARKET 107 5.17.1 INTRODUCTION 107 5.17.2 KEY TARIFF RATES 107 5.17.3 PRICE IMPACT ANALYSIS 108 5.17.4 KEY IMPACTS ON COUNTRIES/REGIONS 108 5.17.4.1 North America 108 5.17.4.1.1 US 108 5.17.4.2 Europe 109 5.17.4.3 Asia Pacific 109 5.17.5 IMPACT ON END-USE INDUSTRIES 109 5.17.5.1 Biobanks 109 5.17.5.2 CROs 110 6 BIOBANKING MARKET, BY OFFERING 111 6.1 INTRODUCTION 112 6.2 PRODUCTS 113 6.2.1 EQUIPMENT 116 6.2.1.1 Freezers & refrigerators 118 6.2.1.1.1 Storage of blood, DNA, and serum to fuel market growth 118 6.2.1.2 Cryogenic storage systems 121 6.2.1.2.1 Rising demand for cell & gene therapies to fuel market 121 6.2.1.3 Alarm & monitoring systems 124 6.2.1.3.1 Regulatory demand for continuous monitoring to support market growth 124 6.2.1.4 Thawing equipment 126 6.2.1.4.1 Growing demand for CAR-T and mRNA therapies to fuel uptake 126 6.2.1.5 Temperature & humidity control systems 129 6.2.1.5.1 Critical role in maintaining sample integrity to aid adoption 129 6.2.1.6 Other equipment & accessories 132 6.2.2 CONSUMABLES 134 6.2.2.1 Surging sample volumes and recurring demand to drive market 134 6.3 SERVICES 137 6.3.1 OUTSOURCING OF SERVICES TO CROS TO DRIVE MARKET 137 6.4 SOFTWARE 140 6.4.1 GROWING FOCUS ON AUTOMATION TO PROPEL MARKET 140 7 BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY OPERATION TYPE 144 7.1 INTRODUCTION 145 7.2 MANUAL OPERATIONS 145 7.2.1 LARGE EXISTING INSTALLED BASE AND NO REQUIREMENT FOR SPECIALIZED LABOR TO DRIVE MARKET 145 7.3 AUTOMATED OPERATIONS 148 7.3.1 INCREASING INNOVATION AND RISING TECHNOLOGICAL ADVANCEMENTS TO PROPEL MARKET 148 8 BIOBANKING PRODUCTS MARKET, BY WORKFLOW 152 8.1 INTRODUCTION 153 8.2 SAMPLE COLLECTION & STORAGE 153 8.2.1 LARGE RESEARCH COHORTS AND SUSTAINABILITY MANDATES TO DRIVE MARKET 153   8.3 SAMPLE PROCESSING 156 8.3.1 AUTOMATION DEMAND AND COMPLIANCE RULES TO FUEL MARKET 156 8.4 SAMPLE ANALYSIS 159 8.4.1 HIGH DEMAND FOR ACTIONABLE DATA TO FUEL MARKET 159 8.5 TRANSPORT & LOGISTICS 162 8.5.1 TEMPERATURE-SENSITIVE REQUIREMENTS TO SUPPORT PRODUCTS UPTAKE 162 9 BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE 166 9.1 INTRODUCTION 167 9.2 BLOOD PRODUCTS 167 9.2.1 EASE OF COLLECTION AND ANALYTICAL VERSATILITY TO PROPEL MARKET 167 9.3 SOLID TISSUES & ORGANS 170 9.3.1 GROWTH IN SPATIAL OMICS TO FUEL MARKET 170 9.4 STEM CELLS & CELL LINES 173 9.4.1 ADOPTION OF REGENERATIVE MEDICINE TO BOOST DEMAND 173 9.5 BIOLOGICAL FLUIDS 175 9.5.1 UTILIZATION FOR DISEASE-MECHANISM STUDIES TO FUEL UPTAKE 175 9.6 NUCLEIC ACIDS 178 9.6.1 INTEGRATION OF MULTI-OMICS TO BOOST DEMAND 178 9.7 HUMAN WASTE PRODUCTS 181 9.7.1 APPLICATIONS ACROSS MICROBIOME RESEARCH TO FUEL UPTAKE 181 10 BIOBANKING PRODUCTS MARKET, BY END USER 184 10.1 INTRODUCTION 185 10.2 BIOBANKS 185 10.2.1 GROWING FOCUS ON LIFE SCIENCES & CLINICAL RESEARCH TO BOOST DEMAND 185 10.3 CROS 188 10.3.1 GROWING FOCUS ON BIOMARKER TRIALS AND OUTSOURCING OF SERVICES TO SUPPORT MARKET 188 11 BIOBANKING SERVICES MARKET, BY OWNERSHIP 192 11.1 INTRODUCTION 193 11.2 PRIVATE/COMMERCIAL BIOBANKS 193 11.2.1 TECHNOLOGICALLY ADVANCED INFRASTRUCTURE AND COMPLIANCE OFFERINGS TO PROPEL MARKET 193 11.3 ACADEMIC & RESEARCH INSTITUTION BIOBANKS 196 11.3.1 FAVORABLE FUNDING ACTIVITIES TO BOOST DEMAND 196 11.4 NATIONAL/REGIONAL AGENCIES 199 11.4.1 GOVERNMENT FOCUS ON ADVANCING HEALTHCARE RESEARCH INITIATIVES TO DRIVE MARKET 199 11.5 HYBRID/PPP MODELS 202 11.5.1 HIGH CREDIBILITY AND AGILITY TO SUPPORT MARKET GROWTH 202 11.6 OTHER OWNERSHIP MODELS 205 12 BIOBANKING MARKET, BY APPLICATION 208 12.1 INTRODUCTION 209 12.2 RESEARCH APPLICATIONS 209 12.2.1 LIFE SCIENCE RESEARCH 212 12.2.1.1 Increasing focus on genomics projects to fuel uptake 212 12.2.2 CLINICAL RESEARCH 215 12.2.2.1 Growing regulatory requirements and decentralized & hybrid trials to support market growth 215 12.3 THERAPEUTIC APPLICATIONS 218 12.3.1 GROWING DEMAND FOR CELL & GENE THERAPIES TO PROPEL MARKET 218 12.4 DIAGNOSTIC APPLICATIONS 220 12.4.1 REQUIREMENT OF DISEASE-SPECIFIC SAMPLES TO BOOST DEMAND 220 12.5 OTHER APPLICATIONS 223 13 BIOBANKING SERVICES MARKET, BY TYPE 226 13.1 INTRODUCTION 227 13.2 PHYSICAL BIOBANKING SERVICES 227 13.2.1 MEGA-COHORTS IN ONCOLOGY & POPULATION GENOMICS TO PROPEL MARKET 227 13.3 VIRTUAL BIOBANKING 230 13.3.1 EASE OF SPECIMEN ACCESS FOR END USERS TO DRIVE MARKET 230 13.4 OTHER SERVICES 233 14 BIOBANKING SERVICES MARKET, BY END USER 236 14.1 INTRODUCTION 237 14.2 PHARMA-BIOTECH COMPANIES & CROS 237 14.2.1 EXPANDING DRUG DISCOVERY & DEVELOPMENT PIPELINE TO PROPEL MARKET 237 14.3 ACADEMIC & RESEARCH INSTITUTES 240 14.3.1 ADVANCEMENTS IN RESEARCH AND FAVORABLE GRANTS TO BOOST DEMAND 240 14.4 HOSPITALS & DIAGNOSTIC LABORATORIES 243 14.4.1 USE OF SAMPLES FOR THERAPEUTIC & DIAGNOSTIC PURPOSES TO AID MARKET 243 15 BIOBANKING MARKET, BY REGION 246 15.1 INTRODUCTION 247 15.2 NORTH AMERICA 247 15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 253 15.2.2 US 254 15.2.2.1 US to dominate North American biobanking market during forecast period 254 15.2.3 CANADA 258 15.2.3.1 Strong public investment with national research networks and collaborations to support disease-focused biobanking 258 15.3 EUROPE 262 15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 267 15.3.2 GERMANY 268 15.3.2.1 High government funding and focus on advanced clinical research to augment market growth 268 15.3.3 UK 273 15.3.3.1 Presence of large-scale, population-based advanced research infrastructure to propel market growth 273 15.3.4 FRANCE 277 15.3.4.1 Growing focus on quality standards, open science, and international collaboration to support market growth 277 15.3.5 ITALY 281 15.3.5.1 Improved healthcare standards to support biobanking studies in cancer, rare diseases, and personalized medicine healthcare 281 15.3.6 SPAIN 286 15.3.6.1 Adoption of international standards and advanced government-backed infrastructure to aid market growth 286 15.3.7 REST OF EUROPE 290 15.4 ASIA PACIFIC 294 15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 300 15.4.2 CHINA 301 15.4.2.1 Increased research collaborations and advancements in biobank infrastructure to drive market 301 15.4.3 JAPAN 305 15.4.3.1 Strong genomic research output and focus on AI-driven polygenic risk scoring to boost predictive healthcare innovation 305 15.4.4 INDIA 309 15.4.4.1 National and disease-specific initiatives for advanced precision medicine and healthcare innovation to aid market growth 309 15.4.5 AUSTRALIA 314 15.4.5.1 Increasing national investments in disease-specific, microbiome, and wildlife biobanks to accelerate market growth 314 15.4.6 SOUTH KOREA 318 15.4.6.1 Increased quality standards and more international collaborations to support human and environmental biobanking 318 15.4.7 REST OF ASIA PACIFIC 323 15.5 LATIN AMERICA 327 15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 332 15.5.2 BRAZIL 333 15.5.2.1 Genetic diversity and large-scale stem cell & genomic initiatives to propel market growth 333 15.5.3 MEXICO 337 15.5.3.1 Favorable initiatives for improving population health research and representation in global genomic databases to drive market 337 15.5.4 REST OF LATIN AMERICA 341 15.6 MIDDLE EAST 346 15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST 351 15.6.2 GCC COUNTRIES 352 15.6.2.1 Kingdom of Saudi Arabia (KSA) 357 15.6.2.1.1 Investments in automated equipment biobank infrastructure, ISO accreditation, and Vision 2030 to boost market growth 357 15.6.2.2 UAE 361 15.6.2.2.1 Investments in AI-driven robotic biobanking to fuel market growth 361 15.6.2.3 Rest of GCC countries 365 15.6.3 REST OF MIDDLE EAST 371 15.7 AFRICA 376 15.7.1 GROWING STANDARDIZATION EFFORTS, INTERNATIONAL ACCREDITATION, AND CAPACITY-BUILDING TO PROPEL MARKET GROWTH 376 15.7.2 MACROECONOMIC OUTLOOK FOR AFRICA 380 16 COMPETITIVE LANDSCAPE 382 16.1 INTRODUCTION 382 16.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN 382 16.3 REVENUE ANALYSIS, 2020–2024 384 16.3.1 REVENUE ANALYSIS FOR BIOBANKING PRODUCTS, 2020–2024 384 16.3.2 REVENUE ANALYSIS FOR BIOBANKING SERVICES & SOFTWARE, 2020–2024 386 16.4 MARKET SHARE ANALYSIS, 2024 386 16.4.1 MARKET SHARE ANALYSIS FOR BIOBANKING PRODUCTS, 2024 386 16.4.2 MARKET SHARE ANALYSIS FOR BIOBANKING SERVICES & SOFTWARE, 2024 388 16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 390 16.5.1 STARS 391 16.5.2 EMERGING LEADERS 391 16.5.3 PERVASIVE PLAYERS 391 16.5.4 PARTICIPANTS 391 16.5.5 COMPANY FOOTPRINT, KEY PLAYERS, 2024 393 16.5.5.1 Company footprint 393 16.5.5.2 Region footprint 394 16.5.5.3 Offering footprint 395 16.5.5.4 Sample type footprint 396 16.5.5.5 Workflow footprint 397 16.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024 397 16.6.1 PROGRESSIVE COMPANIES 397 16.6.2 RESPONSIVE COMPANIES 397 16.6.3 DYNAMIC COMPANIES 398 16.6.4 STARTING BLOCKS 398 16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 399 16.6.5.1 Detailed list of key startups/SMEs 399 16.6.5.2 Competitive benchmarking of startups/ SMEs 400 16.7 COMPANY VALUATION & FINANCIAL METRICS 401 16.7.1 COMPANY VALUATION & FINANCIAL METRICS FOR BIOBANKING PRODUCTS MARKET 401 16.7.1.1 Company valuation 401 16.7.1.2 Financial metrics 401 16.7.2 COMPANY VALUATION & FINANCIAL METRICS FOR BIOBANKING SERVICES & SOFTWARE MARKET 402 16.7.2.1 Company valuation 402 16.7.2.2 Financial metrics 402 16.8 BRAND/PRODUCT COMPARATIVE ANALYSIS 403 16.9 COMPETITIVE SCENARIO 404 16.9.1 PRODUCT/SERVICE/SOLUTION LAUNCHES 404 16.9.2 DEALS 405 16.9.3 EXPANSIONS 406 17 COMPANY PROFILES 407 17.1 KEY PLAYERS 407 17.1.1 THERMO FISHER SCIENTIFIC INC. 407 17.1.1.1 Business overview 407 17.1.1.2 Products/Services/Solutions offered 408 17.1.1.3 Recent developments 414 17.1.1.3.1 Product launches 414 17.1.1.3.2 Deals 415 17.1.1.3.3 Expansions 415 17.1.1.4 MnM view 416 17.1.1.4.1 Key strengths 416 17.1.1.4.2 Strategic choices 416 17.1.1.4.3 Weaknesses & competitive threats 416 17.1.2 PHC HOLDINGS CORPORATION 417 17.1.2.1 Business overview 417 17.1.2.2 Products/Services/Solutions offered 418 17.1.2.3 Recent developments 420 17.1.2.3.1 Product launches 420 17.1.2.4 MnM view 421 17.1.2.4.1 Key strengths 421 17.1.2.4.2 Strategic choices 421 17.1.2.4.3 Weaknesses & competitive threats 421   17.1.3 BECTON, DICKINSON AND COMPANY (BD) 422 17.1.3.1 Business overview 422 17.1.3.2 Products/Services/Solutions offered 423 17.1.3.3 Recent developments 425 17.1.3.3.1 Product launches 425 17.1.3.4 MnM view 426 17.1.3.4.1 Key strengths 426 17.1.3.4.2 Strategic choices 426 17.1.3.4.3 Weaknesses & competitive threats 426 17.1.4 QIAGEN 427 17.1.4.1 Business overview 427 17.1.4.2 Products/Services/Solutions offered 428 17.1.4.3 Recent developments 431 17.1.4.3.1 Product launches 431 17.1.4.4 MnM view 432 17.1.4.4.1 Key strengths 432 17.1.4.4.2 Strategic choices 432 17.1.4.4.3 Weaknesses & competitive threats 432 17.1.5 MERCK KGAA 433 17.1.5.1 Business overview 433 17.1.5.2 Products/Services/Solutions offered 434 17.1.5.3 Recent developments 436 17.1.5.3.1 Expansions 436 17.1.5.4 MnM view 436 17.1.5.4.1 Key strengths 436 17.1.5.4.2 Strategic choices 436 17.1.5.4.3 Weaknesses & competitive threats 436 17.1.6 AVANTOR, INC. 437 17.1.6.1 Business overview 437 17.1.6.2 Products/Services/Solutions offered 438 17.1.6.3 Recent developments 442 17.1.6.3.1 Deals 442 17.1.6.3.2 Expansions 442 17.1.7 CRYOPORT 443 17.1.7.1 Business overview 443 17.1.7.2 Products/Services/Solutions offered 444 17.1.7.3 Recent developments 446 17.1.7.3.1 Product launches 446 17.1.7.3.2 Deals 446 17.1.7.3.3 Expansions 448   17.1.8 TECAN TRADING AG 449 17.1.8.1 Business overview 449 17.1.8.2 Products/Services/Solutions offered 450 17.1.8.3 Recent developments 451 17.1.8.3.1 Product launches 451 17.1.9 AZENTA US INC. 453 17.1.9.1 Business overview 453 17.1.9.2 Products/Services/Solutions offered 454 17.1.9.3 Recent developments 455 17.1.9.3.1 Product launches 455 17.1.9.3.2 Deals 456 17.1.9.3.3 Expansions 456 17.1.10 GREINER AG 457 17.1.10.1 Business overview 457 17.1.10.2 Products/Services/Solutions offered 458 17.1.10.3 Recent developments 459 17.1.10.3.1 Product launches 459 17.1.10.3.2 Expansions 460 17.1.11 AGILENT TECHNOLOGIES, INC. 461 17.1.11.1 Business overview 461 17.1.11.2 Products/Services/Solutions offered 462 17.1.12 LABCORP 463 17.1.12.1 Business overview 463 17.1.12.2 Products/Services/Solutions offered 464 17.1.12.3 Recent developments 465 17.1.12.3.1 Deals 465 17.1.13 EUROFINS SCIENTIFIC 466 17.1.13.1 Business overview 466 17.1.13.2 Products/Services/Solutions offered 467 17.2 OTHER PLAYERS 468 17.2.1 HAIER BIOMEDICAL 468 17.2.2 HAMILTON COMPANY 469 17.2.3 AMSBIO 471 17.2.4 BAY BIOSCIENCES 472 17.2.5 BIOKRYO 473 17.2.6 SPT LABTECH LTD. 474 17.2.7 ASKION GMBH 475 17.2.8 CTIBIOTECH 476 17.2.9 CURELINE 477 17.2.10 FIRALIS MOLECULAR PRECISION 478 17.2.11 SOPACHEM 479 17.2.12 FROILABO 480 17.2.13 BIOIVT 481 18 APPENDIX 482 18.1 DISCUSSION GUIDE 482 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 487 18.3 CUSTOMIZATION OPTIONS 489 18.4 RELATED REPORTS 490 18.5 AUTHOR DETAILS 491
圖表清單 List of Tables & Figures
TABLE 1 BIOBANKING MARKET: INCLUSIONS & EXCLUSIONS 48 TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS 61 TABLE 3 BIOBANKING MARKET: RISK ANALYSIS 65 TABLE 4 BIOBANKING MARKET: IMPACT ANALYSIS 76 TABLE 5 AVERAGE SELLING PRICE OF BIOBANKING PRODUCTS, BY KEY PLAYER, 2024 82 TABLE 6 INDICATIVE PRICING OF BIOBANKING SERVICES, BY SERVICE TYPE, 2024 83 TABLE 7 INDICATIVE PRICING TREND FOR BIOBANKING PRODUCTS, BY REGION, 2022−2024 (USD) 83 TABLE 8 BIOBANKING MARKET: ROLE IN ECOSYSTEM 86 TABLE 9 DETAILED ANALYSIS OF KEY PATENTS IN BIOBANKING MARKET, 2022–2025 90 TABLE 10 BIOBANKING MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025−DECEMBER 2026 93 TABLE 11 BIOBANKING MARKET: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95 TABLE 12 IMPORT DATA FOR HS CODE 8418, BY COUNTRY, 2020–2024 (USD THOUSANDS) 96 TABLE 13 EXPORT DATA FOR HS CODE 8418, BY COUNTRY, 2020–2024 (USD THOUSANDS) 97 TABLE 14 BIOBANKING MARKET: PORTER’S FIVE FORCES 97 TABLE 15 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 100 TABLE 16 BUYING CRITERIA FOR BIOBANKING PRODUCTS MARKET, BY END USER 101 TABLE 17 BUYING CRITERIA FOR BIOBANKING SERVICES, BY END USER 103 TABLE 18 US ADJUSTED RECIPROCAL TARIFF RATES 107 TABLE 19 BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 112 TABLE 20 BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 112 TABLE 21 BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 112 TABLE 22 BIOBANKING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 113 TABLE 23 NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 24 EUROPE: BIOBANKING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 25 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 26 LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 27 MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 115 TABLE 28 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 29 BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY REGION, 2023–2030 (USD MILLION) 116 TABLE 30 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 31 EUROPE: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 32 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 33 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 34 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY REGION, 2023–2030 (USD MILLION) 118 TABLE 35 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 36 BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 37 NORTH AMERICA: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 38 EUROPE: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 39 ASIA PACIFIC: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 40 LATIN AMERICA: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 41 MIDDLE EAST: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS, BY REGION, 2023–2030 (USD MILLION) 120 TABLE 42 GCC COUNTRIES: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 43 BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 44 NORTH AMERICA: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 45 EUROPE: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 46 ASIA PACIFIC: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 47 LATIN AMERICA: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 48 MIDDLE EAST: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 123 TABLE 49 GCC COUNTRIES: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 50 BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 51 NORTH AMERICA: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 52 EUROPE: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 53 ASIA PACIFIC: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 54 LATIN AMERICA: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 55 MIDDLE EAST: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 126 TABLE 56 GCC COUNTRIES: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 57 BIOBANKING MARKET FOR THAWING EQUIPMENT, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 58 NORTH AMERICA: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 59 EUROPE: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 60 ASIA PACIFIC: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 61 LATIN AMERICA: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 62 MIDDLE EAST: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY REGION, 2023–2030 (USD MILLION) 128 TABLE 63 GCC COUNTRIES: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 64 BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 129 TABLE 65 NORTH AMERICA: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 66 EUROPE: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 67 ASIA PACIFIC: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 68 LATIN AMERICA: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 69 MIDDLE EAST: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 131 TABLE 70 GCC COUNTRIES: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 71 BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY REGION, 2023–2030 (USD MILLION) 132 TABLE 72 NORTH AMERICA: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 73 EUROPE: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 74 ASIA PACIFIC: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 75 LATIN AMERICA: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 76 MIDDLE EAST: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 77 GCC COUNTRIES: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 78 BIOBANKING PRODUCTS MARKET FOR CONSUMABLES, BY REGION, 2023–2030 (USD MILLION) 135 TABLE 79 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 80 EUROPE: BIOBANKING PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 81 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 82 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 83 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR CONSUMABLES, BY REGION, 2023–2030 (USD MILLION) 137 TABLE 84 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 85 BIOBANKING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 138 TABLE 86 NORTH AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 87 EUROPE: BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 88 ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 89 LATIN AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 90 MIDDLE EAST: BIOBANKING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 140 TABLE 91 GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 92 BIOBANKING SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION) 141 TABLE 93 NORTH AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 94 EUROPE: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 95 ASIA PACIFIC: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 96 LATIN AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 97 MIDDLE EAST: BIOBANKING SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION) 143 TABLE 98 GCC COUNTRIES: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 99 BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 145 TABLE 100 BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS, BY REGION, 2023–2030 (USD MILLION) 146 TABLE 101 NORTH AMERICA: BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 102 EUROPE: BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 103 ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 104 LATIN AMERICA: BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 105 MIDDLE EAST: BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS, BY REGION, 2023–2030 (USD MILLION) 147 TABLE 106 GCC COUNTRIES: BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS, BY REGION, 2023–2030 (USD MILLION) 148 TABLE 107 BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS, BY REGION, 2023–2030 (USD MILLION) 149 TABLE 108 NORTH AMERICA: BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 109 EUROPE: BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 110 ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 111 LATIN AMERICA: BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 112 MIDDLE EAST: BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS, BY REGION, 2023–2030 (USD MILLION) 150 TABLE 113 GCC COUNTRIES: BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 114 BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 153 TABLE 115 BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY REGION, 2023–2030 (USD MILLION) 154 TABLE 116 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 117 EUROPE: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 118 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 119 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 120 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY REGION, 2023–2030 (USD MILLION) 155 TABLE 121 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION AND STORAGE, BY REGION, 2023–2030 (USD MILLION) 156 TABLE 122 BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING, BY REGION, 2023–2030 (USD MILLION) 157 TABLE 123 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 124 EUROPE: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 125 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 126 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 127 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING, BY REGION, 2023–2030 (USD MILLION) 158 TABLE 128 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 129 BIOBANKING PRODUCTS MARKET FOR SAMPLE ANALYSIS, BY REGION, 2023–2030 (USD MILLION) 160 TABLE 130 NORTH AMERICA: BIOBANKING MARKET FOR SAMPLE ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 131 EUROPE: BIOBANKING MARKET FOR SAMPLE ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 132 ASIA PACIFIC: BIOBANKING MARKET FOR SAMPLE ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 133 LATIN AMERICA: BIOBANKING MARKET FOR SAMPLE ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 134 MIDDLE EAST: BIOBANKING MARKET FOR SAMPLE ANALYSIS, BY REGION, 2023–2030 (USD MILLION) 161 TABLE 135 GCC COUNTRIES: BIOBANKING MARKET FOR SAMPLE ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 136 BIOBANKING PRODUCTS MARKET FOR TRANSPORT & LOGISTICS, BY REGION, 2023–2030 (USD MILLION) 163 TABLE 137 NORTH AMERICA: BIOBANKING MARKET FOR TRANSPORT & LOGISTICS, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 138 EUROPE: BIOBANKING MARKET FOR TRANSPORT & LOGISTICS, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 139 ASIA PACIFIC: BIOBANKING MARKET FOR TRANSPORT & LOGISTICS, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 140 LATIN AMERICA: BIOBANKING MARKET FOR TRANSPORT & LOGISTICS, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 141 MIDDLE EAST: BIOBANKING MARKET FOR TRANSPORT & LOGISTICS, BY REGION, 2023–2030 (USD MILLION) 164 TABLE 142 GCC COUNTRIES: BIOBANKING MARKET FOR TRANSPORT & LOGISTICS, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 143 BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 167 TABLE 144 BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS, BY REGION, 2023–2030 (USD MILLION) 168 TABLE 145 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS, BY REGION, 2023–2030 (USD MILLION) 168 TABLE 146 EUROPE: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 147 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 148 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 149 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS, BY REGION, 2023–2030 (USD MILLION) 169 TABLE 150 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 151 BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY REGION, 2023–2030 (USD MILLION) 170 TABLE 152 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 153 EUROPE: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 154 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 155 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 156 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY REGION, 2023–2030 (USD MILLION) 172 TABLE 157 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 158 BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY REGION, 2023–2030 (USD MILLION) 173 TABLE 159 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 160 EUROPE: BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 161 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 162 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 163 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY REGION, 2023–2030 (USD MILLION) 175 TABLE 164 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 165 BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS, BY REGION, 2023–2030 (USD MILLION) 176 TABLE 166 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 167 EUROPE: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 168 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 169 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 170 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS, BY REGION, 2023–2030 (USD MILLION) 177 TABLE 171 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 172 BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS, BY REGION, 2023–2030 (USD MILLION) 178 TABLE 173 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 174 EUROPE: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 175 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 176 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 177 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS, BY REGION, 2023–2030 (USD MILLION) 180 TABLE 178 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 179 BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY REGION, 2023–2030 (USD MILLION) 181 TABLE 180 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 181 EUROPE: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 182 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 183 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 184 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY REGION, 2023–2030 (USD MILLION) 183 TABLE 185 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 186 BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 185 TABLE 187 BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY REGION, 2023–2030 (USD MILLION) 186 TABLE 188 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION) 186 TABLE 189 EUROPE: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION) 186 TABLE 190 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION) 187 TABLE 191 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION) 187 TABLE 192 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY REGION, 2023–2030 (USD MILLION) 187 TABLE 193 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION) 188 TABLE 194 BIOBANKING PRODUCTS MARKET FOR CROS, BY REGION, 2023–2030 (USD MILLION) 189 TABLE 195 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 196 EUROPE: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 197 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 198 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 199 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR CROS, BY REGION, 2023–2030 (USD MILLION) 190 TABLE 200 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 201 BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 193 TABLE 202 BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY REGION, 2023–2030 (USD MILLION) 194 TABLE 203 NORTH AMERICA: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 204 EUROPE: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 205 ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION) 195 TABLE 206 LATIN AMERICA: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION) 195 TABLE 207 MIDDLE EAST: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY REGION, 2023–2030 (USD MILLION) 195 TABLE 208 GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION) 196 TABLE 209 BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY REGION, 2023–2030 (USD MILLION) 197 TABLE 210 NORTH AMERICA: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 211 EUROPE: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 212 ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 213 LATIN AMERICA: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 214 MIDDLE EAST: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY REGION, 2023–2030 (USD MILLION) 198 TABLE 215 GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION) 199 TABLE 216 BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY REGION, 2023–2030 (USD MILLION) 200 TABLE 217 NORTH AMERICA: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2023–2030 (USD MILLION) 200 TABLE 218 EUROPE: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2023–2030 (USD MILLION) 200 TABLE 219 ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2023–2030 (USD MILLION) 201 TABLE 220 LATIN AMERICA: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2023–2030 (USD MILLION) 201 TABLE 221 MIDDLE EAST: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY REGION, 2023–2030 (USD MILLION) 201 TABLE 222 GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 223 BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS, BY REGION, 2023–2030 (USD MILLION) 203 TABLE 224 NORTH AMERICA: BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 225 EUROPE: BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 226 ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 227 LATIN AMERICA: BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 228 MIDDLE EAST: BIOBANKING SERVICES MARKET FOR HYBRID/PPP BIOBANKS, BY REGION, 2023–2030 (USD MILLION) 204 TABLE 229 GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR HYBRID/PPP BIOBANKS, BY REGION, 2023–2030 (USD MILLION) 205 TABLE 230 BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY REGION, 2023–2030 (USD MILLION) 205 TABLE 231 NORTH AMERICA: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY COUNTRY, 2023–2030 (USD MILLION) 206 TABLE 232 EUROPE: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY COUNTRY, 2023–2030 (USD MILLION) 206 TABLE 233 ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY COUNTRY, 2023–2030 (USD MILLION) 206 TABLE 234 LATIN AMERICA: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY COUNTRY, 2023–2030 (USD MILLION) 207 TABLE 235 MIDDLE EAST: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY REGION, 2023–2030 (USD MILLION) 207 TABLE 236 GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY COUNTRY, 2023–2030 (USD MILLION) 207 TABLE 237 BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 209 TABLE 238 BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 210 TABLE 239 NORTH AMERICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 210 TABLE 240 EUROPE: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 210 TABLE 241 ASIA PACIFIC: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 211 TABLE 242 LATIN AMERICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 211 TABLE 243 MIDDLE EAST: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 211 TABLE 244 GCC COUNTRIES: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 245 BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH, BY REGION, 2023–2030 (USD MILLION) 213 TABLE 246 NORTH AMERICA: BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 213 TABLE 247 EUROPE: BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 213 TABLE 248 ASIA PACIFIC: BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 249 LATIN AMERICA: BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 250 MIDDLE EAST: BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH, BY REGION, 2023–2030 (USD MILLION) 214 TABLE 251 GCC COUNTRIES: BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 215 TABLE 252 BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH, BY REGION, 2023–2030 (USD MILLION) 215 TABLE 253 NORTH AMERICA: BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 216 TABLE 254 EUROPE: BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 216 TABLE 255 ASIA PACIFIC: BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 216 TABLE 256 LATIN AMERICA: BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 257 MIDDLE EAST: BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH, BY REGION, 2023–2030 (USD MILLION) 217 TABLE 258 GCC COUNTRIES: BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 259 BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 218 TABLE 260 NORTH AMERICA: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 218 TABLE 261 EUROPE: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 219 TABLE 262 ASIA PACIFIC: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 219 TABLE 263 LATIN AMERICA: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 219 TABLE 264 MIDDLE EAST: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 220 TABLE 265 GCC COUNTRIES: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 220 TABLE 266 BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 221 TABLE 267 NORTH AMERICA: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 221 TABLE 268 EUROPE: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 221 TABLE 269 ASIA PACIFIC: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 270 LATIN AMERICA: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 271 MIDDLE EAST: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 222 TABLE 272 GCC COUNTRIES: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 223 TABLE 273 BIOBANKING MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 223 TABLE 274 NORTH AMERICA: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 224 TABLE 275 EUROPE: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 224 TABLE 276 ASIA PACIFIC: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 224 TABLE 277 LATIN AMERICA: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 225 TABLE 278 MIDDLE EAST: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 225 TABLE 279 GCC COUNTRIES: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 225 TABLE 280 BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 281 PHYSICAL BIOBANKING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 228 TABLE 282 NORTH AMERICA: PHYSICAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 228 TABLE 283 EUROPE: PHYSICAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 228 TABLE 284 ASIA PACIFIC: PHYSICAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 229 TABLE 285 LATIN AMERICA: PHYSICAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 229 TABLE 286 MIDDLE EAST: PHYSICAL BIOBANKING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 229 TABLE 287 GCC COUNTRIES: PHYSICAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 230 TABLE 288 VIRTUAL BIOBANKING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 230 TABLE 289 NORTH AMERICA: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 231 TABLE 290 EUROPE: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 231 TABLE 291 ASIA PACIFIC: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 231 TABLE 292 LATIN AMERICA: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 232 TABLE 293 MIDDLE EAST: VIRTUAL BIOBANKING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 232 TABLE 294 GCC COUNTRIES: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 232 TABLE 295 OTHER BIOBANKING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 233 TABLE 296 NORTH AMERICA: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 233 TABLE 297 EUROPE: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 298 ASIA PACIFIC: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 299 LATIN AMERICA: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 300 MIDDLE EAST: OTHER BIOBANKING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 235 TABLE 301 GCC COUNTRIES: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 235 TABLE 302 BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 237 TABLE 303 BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS, BY REGION, 2023–2030 (USD MILLION) 238 TABLE 304 NORTH AMERICA: BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS, BY COUNTRY, 2023–2030 (USD MILLION) 238 TABLE 305 EUROPE: BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS, BY COUNTRY, 2023–2030 (USD MILLION) 238 TABLE 306 ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS, BY COUNTRY, 2023–2030 (USD MILLION) 239 TABLE 307 LATIN AMERICA: BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS, BY COUNTRY, 2023–2030 (USD MILLION) 239 TABLE 308 MIDDLE EAST: BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS, BY REGION, 2023–2030 (USD MILLION) 239 TABLE 309 GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS, BY COUNTRY, 2023–2030 (USD MILLION) 240 TABLE 310 BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 240 TABLE 311 NORTH AMERICA: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 241 TABLE 312 EUROPE: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 241 TABLE 313 ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 241 TABLE 314 LATIN AMERICA: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 242 TABLE 315 MIDDLE EAST: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 242 TABLE 316 GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 242 TABLE 317 BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2023–2030 (USD MILLION) 243 TABLE 318 NORTH AMERICA: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 243 TABLE 319 EUROPE: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 244 TABLE 320 ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 244 TABLE 321 LATIN AMERICA: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 244 TABLE 322 MIDDLE EAST: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2023–2030 (USD MILLION) 245 TABLE 323 GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 245 TABLE 324 BIOBANKING MARKET, BY REGION, 2023–2030 (USD MILLION) 247 TABLE 325 NORTH AMERICA: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 248 TABLE 326 NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 327 NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 328 NORTH AMERICA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 249 TABLE 329 NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 250 TABLE 330 NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 250 TABLE 331 NORTH AMERICA: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 251 TABLE 332 NORTH AMERICA: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 251 TABLE 333 NORTH AMERICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 251 TABLE 334 NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 252 TABLE 335 NORTH AMERICA: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 252 TABLE 336 NORTH AMERICA: BIOBANKING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 252 TABLE 337 NORTH AMERICA: KEY MACROINDICATORS 253 TABLE 338 US: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 254 TABLE 339 US: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 340 US: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 341 US: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 255 TABLE 342 US: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 255 TABLE 343 US: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 256 TABLE 344 US: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 345 US: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 256 TABLE 346 US: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 257 TABLE 347 US: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 348 US: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 257 TABLE 349 US: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 258 TABLE 350 CANADA: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 258 TABLE 351 CANADA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 352 CANADA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 353 CANADA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 259 TABLE 354 CANADA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 260 TABLE 355 CANADA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 260 TABLE 356 CANADA: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 357 CANADA: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 261 TABLE 358 CANADA: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 261 TABLE 359 CANADA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 360 CANADA: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 262 TABLE 361 CANADA: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 262 TABLE 362 EUROPE: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 263 TABLE 363 EUROPE: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 364 EUROPE: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 365 EUROPE: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 264 TABLE 366 EUROPE: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 264 TABLE 367 EUROPE: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 264 TABLE 368 EUROPE: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 369 EUROPE: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 265 TABLE 370 EUROPE: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 265 TABLE 371 EUROPE: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 372 EUROPE: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 266 TABLE 373 EUROPE: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 266 TABLE 374 EUROPE: BIOBANKING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 267 TABLE 375 EUROPE: KEY MACROINDICATORS 268 TABLE 376 GERMANY: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 269 TABLE 377 GERMANY: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 378 GERMANY: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 379 GERMANY: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 270 TABLE 380 GERMANY: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 270 TABLE 381 GERMANY: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 270 TABLE 382 GERMANY: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 383 GERMANY: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 271 TABLE 384 GERMANY: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 271 TABLE 385 GERMANY: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 386 GERMANY: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 272 TABLE 387 GERMANY: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 272 TABLE 388 UK: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 273 TABLE 389 UK: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 390 UK: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 274 TABLE 391 UK: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 274 TABLE 392 UK: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 274 TABLE 393 UK: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 275 TABLE 394 UK: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 395 UK: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 275 TABLE 396 UK: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 276 TABLE 397 UK: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 398 UK: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 276 TABLE 399 UK: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 277 TABLE 400 FRANCE: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 277 TABLE 401 FRANCE: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 402 FRANCE: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 403 FRANCE: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 278 TABLE 404 FRANCE: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 279 TABLE 405 FRANCE: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 279 TABLE 406 FRANCE: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 407 FRANCE: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 280 TABLE 408 FRANCE: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 280 TABLE 409 FRANCE: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 410 FRANCE: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 281 TABLE 411 FRANCE: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 281 TABLE 412 ITALY: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 282 TABLE 413 ITALY: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 414 ITALY: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 415 ITALY: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 283 TABLE 416 ITALY: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 283 TABLE 417 ITALY: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 283 TABLE 418 ITALY: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 419 ITALY: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 284 TABLE 420 ITALY: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 284 TABLE 421 ITALY: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 422 ITALY: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 285 TABLE 423 ITALY: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 285 TABLE 424 SPAIN: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 286 TABLE 425 SPAIN: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 426 SPAIN: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 427 SPAIN: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 287 TABLE 428 SPAIN: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 287 TABLE 429 SPAIN: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 288 TABLE 430 SPAIN: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 431 SPAIN: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 288 TABLE 432 SPAIN: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 289 TABLE 433 SPAIN: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 434 SPAIN: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 289 TABLE 435 SPAIN: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 290 TABLE 436 REST OF EUROPE: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 290 TABLE 437 REST OF EUROPE: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 438 REST OF EUROPE: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 439 REST OF EUROPE: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 291 TABLE 440 REST OF EUROPE: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 292 TABLE 441 REST OF EUROPE: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 292 TABLE 442 REST OF EUROPE: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 443 REST OF EUROPE: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 293 TABLE 444 REST OF EUROPE: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 293 TABLE 445 REST OF EUROPE: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 293 TABLE 446 REST OF EUROPE: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 294 TABLE 447 REST OF EUROPE: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 294 TABLE 448 ASIA PACIFIC: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 295 TABLE 449 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 450 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 451 ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 296 TABLE 452 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 297 TABLE 453 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 297 TABLE 454 ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 297 TABLE 455 ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 298 TABLE 456 ASIA PACIFIC: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 298 TABLE 457 ASIA PACIFIC: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 458 ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 299 TABLE 459 ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 299 TABLE 460 ASIA PACIFIC: BIOBANKING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 299 TABLE 461 ASIA PACIFIC: KEY MACROINDICATORS 300 TABLE 462 CHINA: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 301 TABLE 463 CHINA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 464 CHINA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 465 CHINA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 302 TABLE 466 CHINA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 302 TABLE 467 CHINA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 303 TABLE 468 CHINA: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 303 TABLE 469 CHINA: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 303 TABLE 470 CHINA: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 304 TABLE 471 CHINA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 304 TABLE 472 CHINA: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 304 TABLE 473 CHINA: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 305 TABLE 474 JAPAN: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 305 TABLE 475 JAPAN: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 476 JAPAN: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 477 JAPAN: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 306 TABLE 478 JAPAN: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 307 TABLE 479 JAPAN: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 307 TABLE 480 JAPAN: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 307 TABLE 481 JAPAN: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 308 TABLE 482 JAPAN: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 308 TABLE 483 JAPAN: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 308 TABLE 484 JAPAN: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 309 TABLE 485 JAPAN: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 309 TABLE 486 INDIA: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 310 TABLE 487 INDIA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 310 TABLE 488 INDIA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 310 TABLE 489 INDIA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 311 TABLE 490 INDIA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 311 TABLE 491 INDIA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 311 TABLE 492 INDIA: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 312 TABLE 493 INDIA: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 312 TABLE 494 INDIA: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 312 TABLE 495 INDIA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 313 TABLE 496 INDIA: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 313 TABLE 497 INDIA: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 313 TABLE 498 AUSTRALIA: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 314 TABLE 499 AUSTRALIA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 314 TABLE 500 AUSTRALIA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 315 TABLE 501 AUSTRALIA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 315 TABLE 502 AUSTRALIA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 315 TABLE 503 AUSTRALIA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 316 TABLE 504 AUSTRALIA: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 316 TABLE 505 AUSTRALIA: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 317 TABLE 506 AUSTRALIA: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 317 TABLE 507 AUSTRALIA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 317 TABLE 508 AUSTRALIA: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 318 TABLE 509 AUSTRALIA: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 318 TABLE 510 SOUTH KOREA: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 319 TABLE 511 SOUTH KOREA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 512 SOUTH KOREA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 513 SOUTH KOREA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 320 TABLE 514 SOUTH KOREA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 320 TABLE 515 SOUTH KOREA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 320 TABLE 516 SOUTH KOREA: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 321 TABLE 517 SOUTH KOREA: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 321 TABLE 518 SOUTH KOREA: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 321 TABLE 519 SOUTH KOREA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 322 TABLE 520 SOUTH KOREA: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 322 TABLE 521 SOUTH KOREA: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 322 TABLE 522 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 323 TABLE 523 REST OF ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 524 REST OF ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 324 TABLE 525 REST OF ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 324 TABLE 526 REST OF ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 324 TABLE 527 REST OF ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 325 TABLE 528 REST OF ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 529 REST OF ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 326 TABLE 530 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 326 TABLE 531 REST OF ASIA PACIFIC: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 326 TABLE 532 REST OF ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 327 TABLE 533 REST OF ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 327 TABLE 534 LATIN AMERICA: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 328 TABLE 535 LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 536 LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 537 LATIN AMERICA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 329 TABLE 538 LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 329 TABLE 539 LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 329 TABLE 540 LATIN AMERICA: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 541 LATIN AMERICA: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 330 TABLE 542 LATIN AMERICA: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 330 TABLE 543 LATIN AMERICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 544 LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 331 TABLE 545 LATIN AMERICA: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 331 TABLE 546 LATIN AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 332 TABLE 547 LATIN AMERICA: KEY MACROINDICATORS 333 TABLE 548 BRAZIL: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 333 TABLE 549 BRAZIL: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 334 TABLE 550 BRAZIL: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 334 TABLE 551 BRAZIL: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 334 TABLE 552 BRAZIL: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 335 TABLE 553 BRAZIL: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 335 TABLE 554 BRAZIL: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 335 TABLE 555 BRAZIL: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 336 TABLE 556 BRAZIL: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 336 TABLE 557 BRAZIL: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 336 TABLE 558 BRAZIL: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 337 TABLE 559 BRAZIL: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 337 TABLE 560 MEXICO: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 338 TABLE 561 MEXICO: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 338 TABLE 562 MEXICO: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 338 TABLE 563 MEXICO: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 339 TABLE 564 MEXICO: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 339 TABLE 565 MEXICO: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 339 TABLE 566 MEXICO: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 340 TABLE 567 MEXICO: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 340 TABLE 568 MEXICO: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 340 TABLE 569 MEXICO: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 341 TABLE 570 MEXICO: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 341 TABLE 571 MEXICO: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 341 TABLE 572 REST OF LATIN AMERICA: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 342 TABLE 573 REST OF LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 342 TABLE 574 REST OF LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 342 TABLE 575 REST OF LATIN AMERICA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 343 TABLE 576 REST OF LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 343 TABLE 577 REST OF LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 343 TABLE 578 REST OF LATIN AMERICA: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 344 TABLE 579 REST OF LATIN AMERICA: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 344 TABLE 580 REST OF LATIN AMERICA: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 345 TABLE 581 REST OF LATIN AMERICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 345 TABLE 582 REST OF LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 345 TABLE 583 REST OF LATIN AMERICA: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 346 TABLE 584 MIDDLE EAST: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 346 TABLE 585 MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 347 TABLE 586 MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 347 TABLE 587 MIDDLE EAST: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 347 TABLE 588 MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 348 TABLE 589 MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 348 TABLE 590 MIDDLE EAST: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 348 TABLE 591 MIDDLE EAST: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 349 TABLE 592 MIDDLE EAST: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 349 TABLE 593 MIDDLE EAST: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 349 TABLE 594 MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 350 TABLE 595 MIDDLE EAST: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 350 TABLE 596 MIDDLE EAST: BIOBANKING MARKET, BY REGION, 2023–2030 (USD MILLION) 350 TABLE 597 MIDDLE EAST: KEY MACROINDICATORS 351 TABLE 598 GCC COUNTRIES: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 352 TABLE 599 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 600 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 353 TABLE 601 GCC COUNTRIES: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 353 TABLE 602 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 353 TABLE 603 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 354 TABLE 604 GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 354 TABLE 605 GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 355 TABLE 606 GCC COUNTRIES: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 355 TABLE 607 GCC COUNTRIES: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 355 TABLE 608 GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 356 TABLE 609 GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 356 TABLE 610 GCC COUNTRIES: BIOBANKING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 356 TABLE 611 KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 357 TABLE 612 KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 357 TABLE 613 KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 358 TABLE 614 KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 358 TABLE 615 KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 358 TABLE 616 KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 359 TABLE 617 KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 359 TABLE 618 KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 360 TABLE 619 KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 360 TABLE 620 KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 360 TABLE 621 KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 361 TABLE 622 KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 361 TABLE 623 UAE: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 362 TABLE 624 UAE: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 362 TABLE 625 UAE: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 362 TABLE 626 UAE: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 363 TABLE 627 UAE: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 363 TABLE 628 UAE: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 363 TABLE 629 UAE: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 364 TABLE 630 UAE: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 364 TABLE 631 UAE: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 364 TABLE 632 UAE: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 365 TABLE 633 UAE: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 365 TABLE 634 UAE: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 365 TABLE 635 REST OF GCC COUNTRIES: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 366 TABLE 636 REST OF GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 366 TABLE 637 REST OF GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 367 TABLE 638 REST OF GCC COUNTRIES: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 367 TABLE 639 REST OF GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 367 TABLE 640 REST OF GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 368 TABLE 641 REST OF GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 368 TABLE 642 REST OF GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 369 TABLE 643 REST OF GCC COUNTRIES: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 369 TABLE 644 REST OF GCC COUNTRIES: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 369 TABLE 645 REST OF GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 370 TABLE 646 REST OF GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 371 TABLE 647 REST OF MIDDLE EAST: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 371 TABLE 648 REST OF MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 372 TABLE 649 REST OF MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 372 TABLE 650 REST OF MIDDLE EAST: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 372 TABLE 651 REST OF MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 373 TABLE 652 REST OF MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 373 TABLE 653 REST OF MIDDLE EAST: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 374 TABLE 654 REST OF MIDDLE EAST: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 374 TABLE 655 REST OF MIDDLE EAST: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 375 TABLE 656 REST OF MIDDLE EAST: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 375 TABLE 657 REST OF MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 375 TABLE 658 REST OF MIDDLE EAST: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 376 TABLE 659 AFRICA: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 377 TABLE 660 AFRICA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 377 TABLE 661 AFRICA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 377 TABLE 662 AFRICA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION) 378 TABLE 663 AFRICA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 378 TABLE 664 AFRICA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 378 TABLE 665 AFRICA: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 379 TABLE 666 AFRICA: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 379 TABLE 667 AFRICA: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 379 TABLE 668 AFRICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 380 TABLE 669 AFRICA: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 380 TABLE 670 AFRICA: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 380 TABLE 671 AFRICA: KEY MACROINDICATORS 381 TABLE 672 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN THE BIOBANKING MARKET 382 TABLE 673 BIOBANKING PRODUCTS MARKET: DEGREE OF COMPETITION 387 TABLE 674 BIOBANKING SERVICES & SOFTWARE MARKET: DEGREE OF COMPETITION 389 TABLE 675 BIOBANKING MARKET: REGION FOOTPRINT 394 TABLE 676 BIOBANKING MARKET: OFFERING FOOTPRINT 395 TABLE 677 BIOBANKING MARKET: SAMPLE TYPE FOOTPRINT 396 TABLE 678 BIOBANKING MARKET: WORKFLOW FOOTPRINT 397 TABLE 679 BIOBANKING MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 399 TABLE 680 BIOBANKING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY OFFERING AND REGION 400 TABLE 681 BIOBANKING MARKET: PRODUCT/SERVICE/SOFTWARE LAUNCHES, JANUARY 2021–JULY 2025 404 TABLE 682 BIOBANKING MARKET: DEALS, JANUARY 2021–JULY 2025 405 TABLE 683 BIOBANKING MARKET: EXPANSIONS, JANUARY 2021–JULY 2025 406 TABLE 684 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 407 TABLE 685 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 408 TABLE 686 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 414 TABLE 688 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–JULY 2025 415 TABLE 689 PHC HOLDINGS CORPORATION: COMPANY OVERVIEW 417 TABLE 690 PHC HOLDINGS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 418 TABLE 691 PHC HOLDINGS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 420 TABLE 692 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW 422 TABLE 693 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS/SERVICES/ SOLUTIONS OFFERED 423 TABLE 694 BECTON, DICKINSON AND COMPANY (BD): PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 425 TABLE 695 QIAGEN: COMPANY OVERVIEW 427 TABLE 696 QIAGEN: PRODUCTS/SERVICES/SOLUTIONS OFFERED 428 TABLE 697 QIAGEN: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 431 TABLE 699 MERCK KGAA: COMPANY OVERVIEW 433 TABLE 700 MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 434 TABLE 701 MERCK KGAA: EXPANSIONS, JANUARY 2021–JULY 2025 436 TABLE 702 AVANTOR, INC.: COMPANY OVERVIEW 437 TABLE 703 AVANTOR, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 438 TABLE 704 AVANTOR, INC.: DEALS, JANUARY 2021–JULY 2025 442 TABLE 705 AVANTOR, INC.: EXPANSIONS, JANUARY 2021–JULY 2025 442 TABLE 706 CRYOPORT: COMPANY OVERVIEW 443 TABLE 707 CRYOPORT: PRODUCTS/SERVICES/SOLUTIONS OFFERED 444 TABLE 708 CRYOPORT: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 446 TABLE 709 CRYOPORT: DEALS, JANUARY 2021–JULY 2025 446 TABLE 710 CRYOPORT: EXPANSIONS, JANUARY 2021–JULY 2025 448 TABLE 711 TECAN TRADING AG: COMPANY OVERVIEW 449 TABLE 712 TECAN TRADING AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 450 TABLE 713 TECAN TRADING AG: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 451 TABLE 714 TECAN TRADING AG: DEALS, JANUARY 2021–JULY 2025 452 TABLE 715 AZENTA US INC.: COMPANY OVERVIEW 453 TABLE 716 AZENTA US INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 454 TABLE 717 AZENTA US INC.: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 455 TABLE 718 AZENTA US INC.: DEALS, JANUARY 2021–JULY 2025 456 TABLE 719 AZENTA US INC.: EXPANSIONS, JANUARY 2021–JULY 2025 456 TABLE 720 GREINER AG: COMPANY OVERVIEW 457 TABLE 721 GREINER AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 458 TABLE 722 GREINER AG: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 459 TABLE 723 GREINER AG: EXPANSIONS, JANUARY 2021–JULY 2025 460 TABLE 724 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 461 TABLE 725 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 462 TABLE 726 LABCORP: COMPANY OVERVIEW 463 TABLE 727 LABCORP: PRODUCTS/SERVICES/SOLUTIONS OFFERED 464 TABLE 728 LABCORP: DEALS, JANUARY 2021–JULY 2025 465 TABLE 729 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 466 TABLE 730 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 467 TABLE 731 HAIER BIOMEDICAL: COMPANY OVERVIEW 468 TABLE 732 HAMILTON COMPANY: COMPANY OVERVIEW 469 TABLE 733 AMSBIO: COMPANY OVERVIEW 471 TABLE 734 BAY BIOSCIENCES: COMPANY OVERVIEW 472 TABLE 735 BIOKRYO: COMPANY OVERVIEW 473 TABLE 736 SPT LABTECH LTD.: COMPANY OVERVIEW 474 TABLE 737 ASKION GMBH: COMPANY OVERVIEW 475 TABLE 738 CTIBIOTECH: COMPANY OVERVIEW 476 TABLE 739 CURELINE: COMPANY OVERVIEW 477 TABLE 740 FIRALIS MOLECULAR PRECISION: COMPANY OVERVIEW 478 TABLE 741 SOPACHEM: COMPANY OVERVIEW 479 TABLE 742 FROILABO: COMPANY OVERVIEW 480 TABLE 743 BIOIVT: COMPANY OVERVIEW 481 FIGURE 1 BIOBANKING MARKET SEGMENTATION & REGIONAL SCOPE 47 FIGURE 2 BIOBANKING MARKET: YEARS CONSIDERED 49 FIGURE 3 BIOBANKING MARKET: RESEARCH DESIGN 52 FIGURE 4 BIOBANKING MARKET: BREAKDOWN OF PRIMARIES (SUPPLY- AND DEMAND-SIDE PARTICIPANTS) 54 FIGURE 5 BIOBANKING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024 55 FIGURE 6 BIOBANKING PRODUCTS MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2024 56 FIGURE 7 BIOBANKING SERVICES & SOFTWARE MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2024 56 FIGURE 8 ILLUSTRATIVE EXAMPLE OF CRYOPORT, INC.: REVENUE SHARE ANALYSIS, 2024 57 FIGURE 9 BIOBANKING MARKET SIZE VALIDATION FROM PRIMARY SOURCES 58 FIGURE 10 BIOBANKING MARKET: SEGMENTAL MARKET SIZE ESTIMATION (TOP-DOWN APPROACH) 59 FIGURE 11 BIOBANKING MARKET: CAGR PROJECTIONS (2025–2030) 60 FIGURE 12 BIOBANKING MARKET: GROWTH ANALYSIS OF MARKET DYNAMICS 62 FIGURE 13 DATA TRIANGULATION METHODOLOGY 63 FIGURE 14 BIOBANKING MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION) 66 FIGURE 15 BIOBANKING SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 67 FIGURE 16 BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2025 VS. 2030 (USD MILLION) 67 FIGURE 17 BIOBANKING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 68 FIGURE 18 BIOBANKING PRODUCTS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 68 FIGURE 19 BIOBANKING SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 69 FIGURE 20 REGIONAL SNAPSHOT OF BIOBANKING MARKET 69 FIGURE 21 GROWTH IN PRECISION MEDICINE AND CELL & GENE THERAPY R&D TO DRIVE MARKET 72 FIGURE 22 US AND PRODUCTS COMMANDED LARGEST MARKET SHARE IN NORTH AMERICAN BIOBANKING MARKET IN 2024 73 FIGURE 23 BIOBANKS DOMINATED BIOBAKING PRODUCTS MARKET, BY END USER, IN 2024 73 FIGURE 24 PHARMA-BIOTECH COMPANIES & CROS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 74 FIGURE 25 CHINA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD 74 FIGURE 26 BIOBANKING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 75 FIGURE 27 REVENUE SHIFT & NEW REVENUE POCKETS FOR BIOBANKING PRODUCT & SERVICE PROVIDERS 81 FIGURE 28 BIOBANKING MARKET: VALUE CHAIN ANALYSIS 84 FIGURE 29 BIOBANKING MARKET: ECOSYSTEM ANALYSIS 86 FIGURE 30 TOP PATENT APPLICATIONS/OWNERS AND NUMBER OF PATENTS GRANTED IN BIOBANKING MARKET, JANUARY 2014–DECEMBER 2024 89 FIGURE 31 BIOBANKING MARKET: PORTER’S FIVE FORCES ANALYSIS 98 FIGURE 32 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 100 FIGURE 33 KEY BUYING CRITERIA FOR BIOBANKING PRODUCTS, BY END USER 101 FIGURE 34 KEY BUYING CRITERIA FOR BIOBANKING SERVICES, BY END USER 102 FIGURE 35 BIOBANKING MARKET: FUNDING AND NUMBER OF M&A DEALS, 2020−2024 (USD BILLION) 104 FIGURE 36 PE/VC INVESTMENTS IN THE PHARMACEUTICAL SECTOR (2024) 105 FIGURE 37 IMPACT OF AI/GEN AI ON BIOBANKING MARKET ECOSYSTEM 106 FIGURE 38 NORTH AMERICA: BIOBANKING MARKET SNAPSHOT 248 FIGURE 39 ASIA PACIFIC: BIOBANKING MARKET SNAPSHOT 295 FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN BIOBANKING PRODUCTS MARKET, 2020–2024 (USD MILLION) 385 FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN BIOBANKING SERVICES & SOFTWARE MARKET, 2020–2024 (USD MILLION) 386 FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN BIOBANKING PRODUCTS MARKET (2024) 387 FIGURE 43 MARKET SHARE ANALYSIS OF KEY PLAYERS IN BIOBANKING SERVICES & SOFTWARE MARKET (2024) 389 FIGURE 44 BIOBANKING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 392 FIGURE 45 BIOBANKING MARKET: COMPANY FOOTPRINT 393 FIGURE 46 BIOBANKING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 398 FIGURE 47 EV/EBITDA OF KEY PLAYERS 401 FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY PLAYERS 401 FIGURE 49 EV/EBITDA OF KEY PLAYERS 402 FIGURE 50 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY PLAYERS 402 FIGURE 51 BRAND/PRODUCT COMPARATIVE ANALYSIS OF BIOBANKING PRODUCTS 403 FIGURE 52 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 408 FIGURE 53 PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT 418 FIGURE 54 BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT 423 FIGURE 55 QIAGEN: COMPANY SNAPSHOT 428 FIGURE 56 MERCK KGAA: COMPANY SNAPSHOT 434 FIGURE 57 AVANTOR, INC.: COMPANY SNAPSHOT 438 FIGURE 58 CRYOPORT: COMPANY SNAPSHOT 444 FIGURE 59 TECAN TRADING AG: COMPANY SNAPSHOT 450 FIGURE 60 AZENTA US INC.: COMPANY SNAPSHOT 454 FIGURE 61 GREINER AG: COMPANY SNAPSHOT 458 FIGURE 62 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT 462 FIGURE 63 LABCORP: COMPANY SNAPSHOT 464 FIGURE 64 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT 467

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們